Market Highlights:
Stem cell banking is the extraction, processing, and storage of stem cells, so that they may be used for treatment in the future when required. Stem Cells have the amazing power to transform into any tissue or organ in the human body. Stem cells have a unique characteristic & the potential to treat over 80 life-threatening diseases and offers numerous benefits to the baby, its siblings and the family. Furthermore, it is being extensively used in personalized banking, research, and clinical applications. The market study is being classified by Type (Umbilical Cord Blood Stem Cell, Embryonic Stem Cell, Adult Stem Cell and Others), by Application (Personalized Banking Applications, Research Applications {Disease Treatment Studies, Life Science Research, Drug Discovery} and Clinical Applications {HematopOIEtic Disorders, Autoimmune Disorders, Other Diseases}) and major geographies with country level break-up that includes South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico).

Key Players:
The prominent players in the Stem Cell Banking are Cord Blood Registry Systems (United States), Cordlife (Singapore), Cryo-Cell International (United States), Cryo-Save AG (A Subsidiary of Esperite N.V) (Netherlands), LifeCell International (India), StemCyte (United States), ViaCord (A Subsidiary of Perkinelmer) (United States), Global Cord Blood (China), Smart Cells International Ltd. (United Kingdom) and Vita 34 International (Germany).

The Service, such as Sample Preservation and Storage, is boosting the Stem Cell Banking market. Additionally, the rising demand from SMEs and various industry verticals, macro-economic growth are the prime factors driving the growth of the market.

The Source, such as Placental Stem Cells (PSCs), is boosting the Stem Cell Banking market. Additionally, the rising demand from SMEs and various industry verticals, macro-economic growth are the prime factors driving the growth of the market.

Major Market Development Highlights
On 4 June 2018, Cryo-Cell International, Inc., has announced an agreement to acquire substantially all of the assets of Cord:Use Cord Blood Bank, Inc. for a purchase price of 14 Million USD. The acquisition will boost Cryo-Cell International into the public cord blood banking business and is expected to further solidify Cryo-Cell International’s role as the industry leader.
On 21 Nov. 2018, LifeCell, India's premier stem cell bank, has launched their new campaign on television to create awareness and promote umbilical cord stem cell banking for the benefit and protection of the entire family.

Key Questions Answered in the Report
What will the Stem Cell Banking Market size and the growth rate be in Future?
What are the key factors driving the Stem Cell Banking Market?
What are the key market trends and macro-economic impacting the growth of the Stem Cell Banking Market?
What are the challenges to market growth?
Who are the key vendors in the Stem Cell Banking Market?
What are the market opportunities and threats faced by the vendors in the Stem Cell Banking Market?
Trending factors influencing the market shares of the Players.
What are the key outcomes of the five forces analysis of the Stem Cell Banking Market?

Refer complete Table of Content of Stem Cell Banking Market Study

Research Methodology:
The top-down and bottom-up approaches are used to estimate and validate the size of the Global Stem Cell Banking market.
In order to reach an exhaustive list of functional and relevant players various industry classification standards are closely followed such as NAICS, ICB, SIC to penetrate deep in important geographies by players and a thorough validation test is conducted to reach most relevant players for survey in Stem Cell Banking market.
In order to make priority list sorting is done based on revenue generated based on latest reporting with the help of paid databases such as Factiva, Bloomberg etc.
Finally the questionnaire is set and specifically designed to address all the necessities for primary data collection after getting prior appointment by targeting key target audience that includes Private, public, and community stem cell banks, tissue banks, and biobanks, Stem cell associations and organizations, Government regulatory authorities, Regenerative medicine and cellular therapy manufacturers, Pharmaceutical & biopharmaceutical product manufacturers, Healthcare service providers, Research and development (R&D) companies, Clinical research organizations (CROs) and Research laboratories and academic institutes.
This helps us to gather the data for the players’ revenue, operating cycle and expense, profit along with product or service growth etc.
Almost 70-80% of data is collected through primary medium and further validation is done through various secondary sources that includes Regulators, World Bank, Association, Company Website, SEC filings, OTC BB, Annual reports, press releases etc.